Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
Advanced Science · 2023-03 · 10 (8)
DOI: 10.1002/advs.202202519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.01.2023. Verfasst von Lizhen He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, P. R. China. Hauptthemen laut MEDLINE: Quantum Dots, Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China.
Abstract (Originalsprache)
Low persistence, metabolic dysfunction in microenvironment, and tumor‐derived immunosuppression of Natural killer (NK) cells in patients are greatly limited the successful clinical application of NK cell‐based cancer immunotherapy. Interestingly, herein that human serum albumin‐encapsulated black phosphorus quantum dots (BPQDs@HSA) can effectively augment antitumor efficacy of clinical patients‐derived NK cell immunotherapy is found. As the donor of phosphate group, BPQDs@HSA binds with the protein of phosphatidylinositol 4‐phosphate 5‐kinase type‐1 gamma (PIP5K1A) and activates the downstream PI3K‐Akt and mTOR signaling pathways to reprogram cell metabolism of glycolysis and further promote the oxidative phosphorylation, sequentially maintains the cell viability and immunity of NK cells. And multiomics analysis is therefore conducted to reveal the underlying immunoregulation mechanisms, and that BPQDs@HSA can interact with the Toll‐like receptor (TLR) on the NK cell surface and increase the expression level of mTOR, and thus activate downstream NF‐ κ B signalling pathways to regulate cytokine secretion and enhance immune tumoricidal is found. BPQDs@HSA can also enhance immune surveillance, relieve immune suppression, and inhibit tumor immune escape. Collectively, this study not only demonstrates a successful strategy for nanomedicine‐potentiated immune‐cancer therapy, but also sheds light on the understanding of interface between nanomedicine and immune cells activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, P. R. China.
- Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Zhejiang, 310000, P. R. China.
- Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, China.
ORCID-Profile: Hongjun Li, Zhen Gu, Tianfeng Chen
Förderung
- National Key R&D Program of China
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Guangdong Natural Science Foundation
- K. C. Wong Education Foundation
- Natural Science Foundation of Guangdong Province
Zitieren
APA
He, L., Zhao, J., Li, H., Xie, B., Xu, L., Huang, G., Liu, T., Gu, Z., & Chen, T. (2023). Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy. Advanced Science, 10(8). https://doi.org/10.1002/advs.202202519
Vancouver
He L, Zhao J, Li H, Xie B, Xu L, Huang G, et al. Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy. Advanced Science. 2023;10(8). doi:10.1002/advs.202202519
BibTeX
@article{He2023,
author = {He, Lizhen and Zhao, Jianfu and Li, Hongjun and Xie, Bin and Xu, Ligeng and Huang, Guanning and Liu, Ting and Gu, Zhen and Chen, Tianfeng},
title = {Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {8},
doi = {10.1002/advs.202202519}
}
EUVIMED